Login to Your Account

Clinic Roundup

Tuesday, July 10, 2012
• OncoSec Medical Inc., of San Diego, received Investigational Review Board (IRB) approval at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center for a Phase II trial evaluating OncoSec's OMS ElectroImmunotherapy to treat cutaneous T-cell lymphoma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription